Gorgen A - Search Results

1

Serum Factor V Is a Continuous Biomarker of Graft Dysfunction and a Predictor of Graft Loss After Liver Transplantation.

Gorgen A, Prediger C, Prediger JE, Chedid MF, Backes AN, de Araujo A, Grezzana-Filho TJM, Leipnitz I, Chedid AD, Alvares-da-Silva MR, Sapisochin G, Kruel CRP. Gorgen A, et al. Transplantation. 2019 May;103(5):944-951. doi: 10.1097/TP.0000000000002429. Transplantation. 2019. PMID: 30130328

2

Current status of liver transplantation for cholangiocarcinoma.

Goldaracena N, Gorgen A, Sapisochin G. Goldaracena N, et al. Among authors: gorgen a. Liver Transpl. 2018 Feb;24(2):294-303. doi: 10.1002/lt.24955. Liver Transpl. 2018. PMID: 29024405 Review.

3

Patterns and Predictors of Mortality After Waitlist Dropout of Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.

Gorgen A, Rosales R, Sadler E, Beecroft R, Knox J, Dawson LA, Ghanekar A, Grant D, Greig PD, Sapisochin G. Gorgen A, et al. Transplantation. 2019 Oct;103(10):2136-2143. doi: 10.1097/TP.0000000000002616. Transplantation. 2019. PMID: 30801510

4

A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker.

Ivanics T, Salinas-Miranda E, Abreu P, Khalvati F, Namdar K, Dong X, Deniffel D, Gorgen A, Erdman L, Jhaveri K, Haider M, Veit-Haibach P, Sapisochin G. Ivanics T, et al. Among authors: gorgen a. Transplantation. 2021 Nov 1;105(11):2435-2444. doi: 10.1097/TP.0000000000003605. Transplantation. 2021. PMID: 33982917

5

Reply to "Reducing the Safety Limit for Remnant Liver Volume in Living Donor Hepatectomy: Are We Pushing the Envelope Off the Edge?".

Gorgen A, Sapisochin G. Gorgen A, et al. Transplantation. 2021 Jun 1;105(6):e62. doi: 10.1097/TP.0000000000003690. Transplantation. 2021. PMID: 34048420 No abstract available.

6

Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.

Gorgen A, Sapisochin G. Gorgen A, et al. Transplantation. 2021 Jun 1;105(6):e64. doi: 10.1097/TP.0000000000003659. Transplantation. 2021. PMID: 34048422 No abstract available.

7

Reply.

Goldaracena N, Gorgen A, Sapisochin G. Goldaracena N, et al. Among authors: gorgen a. Liver Transpl. 2018 Mar;24(3):441. doi: 10.1002/lt.24971. Epub 2018 Feb 9. Liver Transpl. 2018. PMID: 29125672 No abstract available.

8

Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone?

Gorgen A, Sapisochin G. Gorgen A, et al. Ann Surg. 2021 Jul 1;274(1):e101. doi: 10.1097/SLA.0000000000003606. Ann Surg. 2021. PMID: 31567348 No abstract available.

9

Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival.

Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM. Lee DD, et al. Among authors: gorgen a. Transplantation. 2020 Oct;104(10):2105-2112. doi: 10.1097/TP.0000000000003117. Transplantation. 2020. PMID: 31972705

10

The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study.

Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G. Gorgen A, et al. Transplantation. 2020 Oct;104(10):2087-2096. doi: 10.1097/TP.0000000000003115. Transplantation. 2020. PMID: 31978002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters